Morphological Plaque Characteristics and Clinical Outcomes in Patients With Acute Coronary Syndrome and a Cancer History.


Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
03 08 2021
Historique:
pubmed: 27 7 2021
medline: 25 2 2023
entrez: 26 7 2021
Statut: ppublish

Résumé

Background Although patients with a cancer history have a 2 to 3 times higher risk for acute coronary syndrome (ACS), the morphological characteristics of ACS culprit plaque in those patients and their relations with clinical outcomes remain unknown. Methods and Results This retrospective, multicenter, observational cohort study included consecutive patients with ACS who underwent optical coherence tomography-guided emergent percutaneous coronary intervention. Patients were categorized into those without a cancer history, those with a cancer history, and those currently receiving cancer treatment. ACS culprit lesions were classified as plaque rupture, plaque erosion, or calcified nodule using optical coherence tomography. Plaque erosion frequency was significantly higher in culprit lesions of patients with current cancer and patients with cancer history than in those of patients without cancer history (56.3% versus 61.7% versus 36.5%). Calcified nodule incidence was significantly higher in patients without cancer history than in patients with current cancer and patients without cancer history (patients with current cancer: 12.4% versus patients without cancer history: 25.5% versus patients without cancer history: 12.6%,

Identifiants

pubmed: 34308680
doi: 10.1161/JAHA.120.020243
pmc: PMC8475681
doi:

Banques de données

UMIN-CTR
['UMIN000038442']

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e020243

Références

J Am Heart Assoc. 2019 May 7;8(9):e011820
pubmed: 31057022
Int J Cardiol. 2016 Jan 15;203:766-74
pubmed: 26590891
Circulation. 1995 Oct 1;92(7):1701-9
pubmed: 7671351
Circulation. 2016 Mar 15;133(11):1104-14
pubmed: 26976915
Thromb Res. 2000 Sep 1;99(5):503-9
pubmed: 10973681
Circulation. 2016 Mar 29;133(13):1272-89
pubmed: 27022039
Am J Cardiol. 2010 Jun 15;105(12):1673-8
pubmed: 20538113
Heart Vessels. 2012 Nov;27(6):634-8
pubmed: 22218740
J Am Coll Cardiol. 2014 May 13;63(18):1845-54
pubmed: 24561145
Am J Cardiol. 2013 Dec 15;112(12):1867-72
pubmed: 24063839
Eur J Cancer. 2012 Jan;48(1):121-8
pubmed: 22023886
Eur Heart J. 2007 Apr;28(8):961-7
pubmed: 17135281
Eur Heart J Acute Cardiovasc Care. 2018 Oct;7(7):631-638
pubmed: 28593789
J Am Coll Cardiol. 2014 Dec 2;64(21):2207-17
pubmed: 25456755
J Thorac Dis. 2018 Dec;10(Suppl 35):S4367-S4385
pubmed: 30701104
J Am Heart Assoc. 2015 Nov 09;4(11):
pubmed: 26553214
Cardiology. 2018;139(2):90-100
pubmed: 29301128
Medicine (Baltimore). 2019 Nov;98(44):e17602
pubmed: 31689764
J Am Coll Cardiol. 2018 Oct 30;72(18):2231-2264
pubmed: 30153967
Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):656-65
pubmed: 20159360
Curr Oncol Rep. 2016 Mar;18(3):15
pubmed: 26838585
N Engl J Med. 2017 Sep 21;377(12):1119-1131
pubmed: 28845751
Eur Heart J. 2015 Jun 7;36(22):1377-84
pubmed: 25713314
Eur Heart J Qual Care Clin Outcomes. 2018 Oct 1;4(4):290-300
pubmed: 29211884
Anadolu Kardiyol Derg. 2014 Nov;14(7):661
pubmed: 25163088
J Am Coll Cardiol. 2017 Aug 22;70(8):926-938
pubmed: 28818202
J Am Coll Cardiol. 2013 Nov 5;62(19):1748-58
pubmed: 23810884
J Clin Oncol. 2012 Aug 20;30(24):2963-8
pubmed: 22778320
Catheter Cardiovasc Interv. 2018 Feb 15;91(S1):582-590
pubmed: 29359491
JACC Cardiovasc Interv. 2015 Aug 17;8(9):1166-1176
pubmed: 26117464

Auteurs

Kosuke Tanimura (K)

Division of Cardiovascular Medicine Department of Internal Medicine Kobe University Graduate School of Medicine Kobe Japan.

Hiromasa Otake (H)

Division of Cardiovascular Medicine Department of Internal Medicine Kobe University Graduate School of Medicine Kobe Japan.

Hiroyuki Kawamori (H)

Division of Cardiovascular Medicine Department of Internal Medicine Kobe University Graduate School of Medicine Kobe Japan.

Takayoshi Toba (T)

Division of Cardiovascular Medicine Department of Internal Medicine Kobe University Graduate School of Medicine Kobe Japan.

Akira Nagasawa (A)

Division of Cardiovascular Medicine Department of Internal Medicine Kobe University Graduate School of Medicine Kobe Japan.

Shinsuke Nakano (S)

Division of Cardiovascular Medicine Department of Internal Medicine Kobe University Graduate School of Medicine Kobe Japan.

Yu Takahashi (Y)

Division of Cardiovascular Medicine Department of Internal Medicine Kobe University Graduate School of Medicine Kobe Japan.

Yusuke Fukuyama (Y)

Division of Cardiovascular Medicine Department of Internal Medicine Kobe University Graduate School of Medicine Kobe Japan.

Amane Kozuki (A)

Division of Cardiovascular Medicine Osaka Saiseikai Nakatsu Hospital Osaka Japan.

Junya Shite (J)

Division of Cardiovascular Medicine Osaka Saiseikai Nakatsu Hospital Osaka Japan.

Masamichi Iwasaki (M)

Department of Cardiology Hyogo Prefectural Awaji Medical Center Sumoto Japan.

Koji Kuroda (K)

Department of Cardiology Hyogo Prefectural Awaji Medical Center Sumoto Japan.

Tomofumi Takaya (T)

Division of Cardiovascular Medicine Hyogo Prefectural Himeji Cardiovascular Center Himeji Japan.

Ken-Ichi Hirata (KI)

Division of Cardiovascular Medicine Department of Internal Medicine Kobe University Graduate School of Medicine Kobe Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH